Strong Week for Ji Yao Holding Group (SZSE:300108) Shareholders Doesn't Alleviate Pain of Five-year Loss
Strong Week for Ji Yao Holding Group (SZSE:300108) Shareholders Doesn't Alleviate Pain of Five-year Loss
Over the last month the Ji Yao Holding Group Co., Ltd. (SZSE:300108) has been much stronger than before, rebounding by 32%. But that doesn't change the fact that the returns over the last five years have been less than pleasing. After all, the share price is down 24% in that time, significantly under-performing the market.
在过去的一个月里,st吉药集团股份有限公司(SZSE:300108)比以往任何时候都要强大得多,反弹了32%。 但这并不改变过去五年的回报令人不满的事实。 毕竟,股价在那个时期下跌了24%,明显低于市场表现。
On a more encouraging note the company has added CN¥360m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.
更令人鼓舞的是,该公司在过去的7天内已经为市值增加了36000万人民币,让我们看看是什么导致了股东们五年的亏损。
Because Ji Yao Holding Group made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally hope to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.
因为st吉药集团在过去十二个月中亏损,我们认为市场可能更专注于营业收入和营业收入增长,至少目前是这样。 当一家公司没有利润时,我们通常希望看到良好的营业收入增长。 你可以想象,快速的营业收入增长,如果能保持,通常会导致快速的利润增长。
Over half a decade Ji Yao Holding Group reduced its trailing twelve month revenue by 23% for each year. That puts it in an unattractive cohort, to put it mildly. On the face of it we'd posit the share price fall of 4% compound, over five years is well justified by the fundamental deterioration. We doubt many shareholders are delighted with this share price performance. It is possible for businesses to bounce back but as Buffett says, 'turnarounds seldom turn'.
在半个多世纪的时间里,st吉药集团每年的滚动十二个月营业收入下降了23%。 这使其成为一个不太吸引人的队伍,委婉地说。 从表面上看,我们认为,在过去五年里,股价下跌了4%,这在根本上是合理的。 我们怀疑很多股东对这种股价表现感到高兴。 企业有可能东山再起,但正如巴菲特所说,“转机很少有转机”。
You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).
您可以在下方图片中看到盈利和营业收入随时间的变化(单击图表查看准确数值)。
You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.
你可以在这个免费的互动图表中看到它的资产负债表如何随着时间的推移而加强(或削弱)。
A Different Perspective
另一种看法
Investors in Ji Yao Holding Group had a tough year, with a total loss of 8.1%, against a market gain of about 5.2%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 4% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 3 warning signs for Ji Yao Holding Group you should be aware of.
吉药控股集团的投资者经历了艰难的一年,整体亏损了8.1%,而市场收益约为5.2%。然而,请记住,即使是最好的股票有时也会在十二个月的期间表现不佳。遗憾的是,去年的表现为一段糟糕的运行画上了句号,股东们在过去五年中每年面临着4%的总亏损。我们意识到,罗斯柴尔德男爵曾说投资者应该在“街上血流成河”的时候买入,但我们警告投资者应首先确保他们购买的是高质量的业务。我发现长期观察股价作为业绩的替代方案非常有意思。但要真正获得见解,我们需要考虑其他信息。例如:我们发现了吉药控股集团的3个警示信号,您应该注意。
We will like Ji Yao Holding Group better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.
如果我们看到一些大规模内部人士的买入行为,我们将更喜欢吉药控股集团。在等待期间,请查看这份免费的被低估的股票名单(主要是小市值股票),其中包括可观的最近内部人员购买。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
请注意,本文中引用的市场回报反映了目前在中国交易所上市的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。